Form 4 for RGEN REPLIGEN CORP

Accepted 2022-05-31 00:00:00 ET · period of report 2022-05-26 · accession 0000899243-22-020272 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-05-31	2022-05-26	RGEN	EGLINTON MANNER CARRIE	Dir	A - Grant	$0.00	+1,024	1,481	+224%	$0
D	2022-05-31	2022-05-26	RGEN	EGLINTON MANNER CARRIE	Dir	A - Grant	$0.00	+2,488	2,488	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-05-26	A	A	1,024	$0.00	1,481	D	—	—	(F1) Ms. Eglinton Manner was awarded 1,024 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 26, 2023, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
2	Derivative	Stock Option (Right to Buy)	2022-05-26	A	A	2,488	$0.00	2,488	D	$159.17 · 2023-05-26 to 2032-05-26	2,488 Common Stock	(F2) Award vests in full on the earlier of May 26, 2023, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.